Beta Bionics Inc (NASDAQ:BBNX) shares, rose in value on Friday, March 28, with the stock price down by -7.58% to the previous day’s close as strong demand from buyers drove the stock to $11.71.
Actively observing the price movement in the last trading, the stock closed the session at $12.67, falling within a range of $11.43 and $12.55. Referring to stock’s 52-week performance, its high was $24.50, and the low was $12.11. On the whole, BBNX has fluctuated by -41.19% over the past month.
With the market capitalization of Beta Bionics Inc currently standing at about $507.63 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 82.68M, with a low estimate of 15M and a high estimate of 18.12M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 16.15M.
The stock’s technical analysis shows that the price of BBNX currently trading nearly -24.77% and -37.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 22.85, while the 7-day volatility ratio is showing 11.38% which for the 30-day chart, stands at 10.42%. Furthermore, Beta Bionics Inc (BBNX)’s average true range (ATR) is 1.44.
Data on historical trading for Beta Bionics Inc (NASDAQ:BBNX) indicates that the trading volumes over the past 10 days have averaged 0.86 and over the past 3 months, they’ve averaged 649.52K. According to company’s latest data on outstanding shares, there are 43.35 million shares outstanding.
Nearly 18.78% of Beta Bionics Inc’s shares belong to company insiders and institutional investors own 38.03% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.21 million shares as on 2025-03-14, resulting in a short ratio of 3.43. The stock has fallen by -50.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BBNX stock heading into the next quarter.
